Reza MBA - Surrozen Warrant VP Strategy

SRZNW Stock  USD 0.02  0.01  21.74%   

Insider

Reza MBA is VP Strategy of Surrozen Warrant
Address 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Phone650 489 9000
Webhttps://www.surrozen.com

Surrozen Warrant Management Efficiency

The company has return on total asset (ROA) of (0.3265) % which means that it has lost $0.3265 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.7359) %, meaning that it generated substantial loss on money invested by shareholders. Surrozen Warrant's management efficiency ratios could be used to measure how well Surrozen Warrant manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.98 in 2024. Return On Capital Employed is likely to drop to -1.23 in 2024. At this time, Surrozen Warrant's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 3.4 M in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 740.1 K in 2024.
Surrozen Warrant has accumulated 3.38 M in total debt with debt to equity ratio (D/E) of 0.38, which is about average as compared to similar companies. Surrozen Warrant has a current ratio of 2.68, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Note, when we think about Surrozen Warrant's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Marc StapleyVeracyte
54
Lisa MDVivani Medical
60
Dominic CundariDiaMedica Therapeutics
73
Joseph MaraVericel Corp Ord
48
Kayte FischerVivani Medical
N/A
Jonathan WygantVeracyte
53
MB FRCSEdVericel Corp Ord
62
Brigid MakesVivani Medical
68
Marc TessierLavigneDenali Therapeutics
64
Scott CADiaMedica Therapeutics
59
Beverly CPAVeracyte
61
Alexander MDDenali Therapeutics
51
Tracy MorrisVeracyte
N/A
Joel RothmanEquillium
55
Annie McGuireVeracyte
44
Krishna MDEquillium
51
Maurice ZaudererVaccinex
78
Edward CalamaiDiaMedica Therapeutics
N/A
MBA CFAVaccinex
50
Laetitia BachelotFontaineValneva SE ADR
N/A
Elizabeth EvansVaccinex
51
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. The company was founded in 2016 and is headquartered in South San Francisco, California. Consonance-Hfw Acq operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. Surrozen Warrant (SRZNW) is traded on NASDAQ Exchange in USA. It is located in 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 and employs 42 people. Surrozen Warrant is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Surrozen Warrant Leadership Team

Elected by the shareholders, the Surrozen Warrant's board of directors comprises two types of representatives: Surrozen Warrant inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surrozen. The board's role is to monitor Surrozen Warrant's management team and ensure that shareholders' interests are well served. Surrozen Warrant's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surrozen Warrant's outside directors are responsible for providing unbiased perspectives on the board's policies.
Charles Williams, Chief Officer
Roeland Nusse, CoFounder Advisor
Sheela MohanPeterson, VP Legal
Esther Jhun, Controller
Reza MBA, VP Strategy
MBA MD, Chief Officer
Craig MBA, President CEO
Johannes MD, CoFounder Advisor
Li Yang, Executive Research
WenChen MD, Chief Officer
Calvin MD, CoFounder Advisor
Christopher Garcia, CoFounder Advisor
Calvin Kuo, CoFounder Advisor

Surrozen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Surrozen Warrant a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surrozen Stock Analysis

When running Surrozen Warrant's price analysis, check to measure Surrozen Warrant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surrozen Warrant is operating at the current time. Most of Surrozen Warrant's value examination focuses on studying past and present price action to predict the probability of Surrozen Warrant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surrozen Warrant's price. Additionally, you may evaluate how the addition of Surrozen Warrant to your portfolios can decrease your overall portfolio volatility.